|
WO2020256084A1
|
|
Crosslinked nucleoside intermediate crystal and method for producing same, and method for producing crosslinked nucleoside amidite
|
|
WO2020179714A1
|
|
Practical enzymatic synthesis of 3',3'-cgamp
|
|
WO2020090948A1
|
|
Cyclic-di-amp sodium salt crystal
|
|
WO2020050208A1
|
|
Method and kit for rapid measurement of autoantibody activity with respect to tsh receptor
|
|
WO2020032152A1
|
|
Stereoselective synthesis method for 4'-substituted nucleoside derivative
|
|
CA3104609A1
|
|
Hydrate crystal of 3',3'-cgamp
|
|
US2019159495A1
|
|
Method for short-time koji production using pre-cultured filamentous fungi
|
|
CN111868067A
|
|
Nucleoside derivatives and use thereof
|
|
WO2018181102A1
|
|
Nucleoside derivative or salt thereof, and pharmaceutical composition containing same
|
|
WO2018110643A1
|
|
Nucleoside derivative exhibiting antiviral activity
|
|
WO2018110591A1
|
|
2'-deoxy-7-deazapurine nucleoside derivative having antiviral activity
|
|
US2019233462A1
|
|
Method for purifying P1,P4-di(uridine 5′-)tetraphosphate
|
|
KR20180009744A
|
|
Method for storing P1, P4-bis (5'-uracil) tetrafluorate crystal
|
|
CA2942283A1
|
|
Inclusion compound of 3',5'-cyclic diadenylic acid and manufacturing method thereof
|
|
CA2941353A1
|
|
Crystalline 3',5'-cyclic diguanylic acid
|
|
WO2014103704A1
|
|
Method for producing p1,p4-di(uridine 5'-)tetraphosphate
|
|
EP2843046A1
|
|
Practical method for enzymatically synthesizing cyclic di-gmp
|
|
WO2012070601A1
|
|
Novel 2-alkynyl-n9-propargyladenine and medicinal use thereof
|
|
KR20130136984A
|
|
Hair growth agent composition
|
|
WO2010150791A1
|
|
Process for production of adenosine tetraphosphate compound
|
